Seger starts development of intracorporeal anastomosis laparoscopic device
Seger Surgical Solutions has commenced the development of its next-generation laparoscopic bowel closure device for intracorporeal anastomosis. The new device,…
Seger Surgical Solutions has commenced the development of its next-generation laparoscopic bowel closure device for intracorporeal anastomosis. The new device,…
SomaLogic has collaborated with Illumina to co-develop next-generation sequencing (NGS)-based proteomic solutions. Under the multi-year partnership deal, the companies will…
Researchers at the University of Oxford in the UK have developed a new type of blood test, which can be…
The Australian Competition and Consumer Commission (ACCC) has announced a review of Covid-19 rapid antigen test prices and is contacting…
Researchers at the University of Illinois Chicago (UIC) in the US have identified a biomarker to track depression and antidepressant…
Finnish medical device firm Bioretec has submitted an application seeking CE mark for its bioresorbable RemeOs trauma screw to commercialise…
Sorrento Therapeutics has announced that the initial testing of its COVISTIX Covid-19 virus rapid antigen detection test showed its ability…
The US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to Roche's COVID-19 At-Home Test. A rapid…
Global life sciences firm Labcorp has signed a definitive agreement to acquire Personal Genome Diagnostics (PGDx) in a deal valued…
genedrive has submitted an application seeking approval to sell its rapid molecular test, Genedrive COV19-ID Kit in the UK under…